Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.

Doctors gave one teenager with Lesch-Nyhan syndrome a daily pill combo: 5-HTP plus carbidopa.

They watched his self-biting, blood chemistry, and brain chemicals for several weeks.

This was a single-case test, not a big trial.

The boy stopped biting himself for a short while.

His serotonin and other brain chemicals moved toward normal.

After a few weeks the benefit faded and his thinking skills stayed the same.

Rose et al. (2000) later reviewed stronger pills called SRIs (like clomipramine) for autism. They saw similar short-lived drops in repetitive and harmful acts.

Ghaziuddin et al. (1996) tried buspirone, another serotonin drug, in eight adults with ID. Self-injury fell, but—like here—the proof came from small open cases, not controlled trials.

Guinchat et al. (2015) showed that catching hidden pain or other diagnoses helps behavioral crises far more than any pill alone. Their bigger gains remind us to rule out medical causes first.

5-HTP can give a brief pause in severe self-bite cases, so you might use it as a bridge while you set up stronger supports. Plan for the fade: start behavioral skills training, sensory tools, and medical screens early. Tell families the calm may be temporary and keep data every day so you can taper safely when the effect slips.